MINVX | VSTSX | MINVX / VSTSX | |
Total Expense Ratio | 0.91 | 0.01 | 9,100% |
Annual Report Gross Expense Ratio | 0.91 | 0.01 | 9,100% |
Fund Existence | 47 years | 9 years | - |
Gain YTD | -0.138 | 1.376 | -10% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 5000000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 415M | 1.82T | 0% |
Annual Yield % from dividends | 0.59 | 1.29 | 45% |
Returns for 1 year | 1.84 | 10.09 | 18% |
Returns for 3 years | 27.47 | 57.70 | 48% |
Returns for 5 years | 36.99 | 91.51 | 40% |
Returns for 10 years | 43.07 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FEIKX | 78.33 | N/A | N/A |
Fidelity Equity-Income K | |||
LYFCX | 11.93 | -0.07 | -0.58% |
AlphaCentric Life Sciences & Hlthcare C | |||
NIEAX | 18.21 | -0.23 | -1.25% |
BNY Mellon International Equity A | |||
IMORX | 16.99 | -0.24 | -1.39% |
Voya MidCap Opportunities R | |||
TFIFX | 44.13 | -0.90 | -2.00% |
T. Rowe Price Financial Services I |